Nicole Sweeny
Net worth: 2 M $ as of 2026-05-30
Net worth: 2 M $ as of 2026-05-30
Nicole Sweeny is currently Director at Monopar Therapeutics, Inc. and Chief Commercial Officer at KalVista Pharmaceuticals, Inc. Formerly, Ms. Sweeny was Vice President-US Marketing at Shire Plc from 2017 to 2019, Vice President-Franchise Head at Takeda Pharmaceuticals U.S.A., Inc. from 2019 to 2020, and Chief Commercial Officer at Praxis Precision Medicines, Inc. from 2020 to 2023.
Ms. Sweeny completed undergraduate education at Boston College.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-05-25 | 59,291 ( 0.12% ) | 2 M $ | 2026-05-30 |
| Companies | Position | Start |
|---|---|---|
| KALVISTA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 2023-07-24 |
| MONOPAR THERAPEUTICS INC. | Director/Board Member | - |
| Companies | Position | End |
|---|---|---|
| PRAXIS PRECISION MEDICINES, INC. | Corporate Officer/Principal | 2023-03-30 |
Takeda Pharmaceuticals U.S.A., Inc.
Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Corporate Officer/Principal | 2020-06-30 |
| SHIRE | Corporate Officer/Principal | 2018-12-31 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 6 |
|---|---|
Shire Plc
Shire Plc Pharmaceuticals: MajorHealth Technology Develops and markets medicines for patients with rare diseases | Health Technology |
Boston College
Boston College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Takeda Pharmaceuticals U.S.A., Inc.
Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
Monopar Therapeutics, Inc.
Monopar Therapeutics, Inc. BiotechnologyHealth Technology Develops drugs for cancer disease | Health Technology |
Praxis Precision Medicines, Inc.
Praxis Precision Medicines, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company which develops therapies for central nervous system disorders | Health Technology |
KalVista Pharmaceuticals, Inc.
KalVista Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets small molecule protease inhibitors for diseases | Health Technology |
Select your edition
All financial news and data tailored to specific country editions